JIP
IDXX icon

Jaffetilchin Investment Partners’s Idexx Laboratories IDXX Stock Holding History

Jaffetilchin Investment Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6
Closed -$3.03K – 793
2024
Q3 		$3.03K Buy
+6
New +$2.92K ﹤0.01% 1122
2018
Q4 		– Sell
-2,089
Closed -$522K – 303
2018
Q3 		$522K Buy
2,089
+85
+4% +$20.6K 0.11% 153
2018
Q2 		$437K Buy
+2,004
New +$413K 0.1% 182
2017
Q4 		– Sell
-2,320
Closed -$361K – 262
2017
Q3 		$361K Buy
2,320
+61
+3% +$9.64K 0.09% 212
2017
Q2 		$365K Sell
2,259
-617
-21% -$100K 0.12% 142
2017
Q1 		$445K Hold
2,876
– – 0.11% 149
2016
Q4 		$337K Buy
2,876
+188
+7% +$21.5K 0.1% 171
2016
Q3 		$303K Buy
+2,688
New +$283K 0.1% 167
2014
Q3 		– Sell
-13,326
Closed -$890K – 221
2014
Q2 		$890K Buy
+13,326
New +$847K 0.32% 44
2014
Q1 		– Sell
-5,892
Closed -$313K – 202
2013
Q4 		$313K Buy
+5,892
New +$310K 0.15% 139

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jaffetilchin Investment Partners's IDXX Position: Q4 2024 in Review

Jaffetilchin Investment Partners sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 6 shares — an estimated $3.03K sold.

Jaffetilchin Investment Partners first reported a position in IDXX in Q4 2013 and held it in 10 quarters. The position peaked at $890K in Q2 2014. 1,124 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • Jaffetilchin Investment Partners reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 6 Idexx Laboratories shares in Q4 2024, an estimated $3.03K.
  • Jaffetilchin Investment Partners first reported a position in Idexx Laboratories in Q4 2013 and held it in 10 quarters.
  • Jaffetilchin Investment Partners's Idexx Laboratories position peaked at $890K in Q2 2014.
  • 1,124 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.